1. Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

You may or may not get credit for those new writers.

Discussion in 'Exact Sciences' started by anonymous, Apr 5, 2016 at 5:33 PM.

  1. anonymous

    anonymous Guest

    It's about the mission here. If you don't get credit, help your new M.R. transition into that office. I love my job. Yay!
     
  2. anonymous

    anonymous Guest

    Do NOT try getting new writers on board until you are sure you will be getting credit for them. Usually, when management won't give you a straight answer, it's NO. Fuck these people.